Overview
- Provides comprehensive overview on how neuroproteomics helped depicting the molecular features of schizophrenia
- Addresses biological processes, treatment strategies, and recent research findings associated to schizophrenia
- Addresses current research challenges, future strategies, and clinical applications
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1400)
Part of the book sub series: Proteomics, Metabolomics, Interactomics and Systems Biology (PMISB)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (10 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Over the past decade, neuroproteomics has shed light on the molecular features of schizophrenia by depicting biological processes involved with its establishment, maintenance and treatment. These studies have also pointed to potential biomarkers applicable to diagnosis and medication monitoring. Edited by a leader in the field of neuroproteomics with contributions from subject experts, this new volume will address recent findings and compile evidence from difference perspectives—such as human samples, animal models, pluripotent stem cell-derived in vitro pre-clinical models—and provide findings to inform the development of innovative future treatment strategies.
This volume will be useful for a broad audience of researchers and professionals, including biologists, neurologists, psychiatrists, analytical chemists, and pharmacists, among others.
Editors and Affiliations
About the editor
Daniel Martins-de-Souza holds a PhD in Biochemistry and Molecular Biology and is an Associate Professor of Biochemistry and Head of Proteomics at the University of Campinas (UNICAMP), in Brazil. Daniel´s postdoctoral training was carried out in the Max Planck Institute of Psychiatry in Germany and at the University of Cambridge, in the UK. For two years, Daniel was Principal Investigator in the Dept. of Psychiatry and Psychotherapy of the Ludwig Maximilians University (LMU), just before becoming a Professor. Daniel was elected Affiliated Member of the São Paulo Academy of Sciences in 2019 and Affiliated Member of the Brazilian Academy of Sciences in 2017. He is part of the Editorial Board of seven indexed journals and Associate Editor for npj Schizophrenia. His main expertise is on proteomics and systems biology tools to investigate molecular mechanisms involved in mental disorders.
Bibliographic Information
Book Title: Neuroproteomics as a Tool for Understanding Schizophrenia
Editors: Daniel Martins-de-Souza
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-3-030-97182-3
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
Hardcover ISBN: 978-3-030-97181-6Published: 06 August 2022
eBook ISBN: 978-3-030-97182-3Published: 05 August 2022
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: VIII, 143
Number of Illustrations: 1 b/w illustrations, 11 illustrations in colour
Topics: Genetics and Genomics, Bioinformatics, Neurosciences